Treatment for substance use disorders in a privately, insured population under managed care: Costs and services use

The study investigated the relationship of substance use disorders, concurrent psychiatric disorders. and patient demographics to patients of treatment use and spending in behavioral health and medical treatment sectors. We examined claims data for individuals covered by the same organization. Services spending and use were examined for 1899 individuals who received substance use disorder treatment in 1997. Medical and pharmacy spending was assessed for 590 individuals (31.1%). The most prevalent services were outpatient, intensive outpatient, residential, and detoxification. Average mental health/substance abuse (MHSA) care spending conditional on use was highest for those with concurrent alcohol and drug disorders (S5235) compared to those with alcohol (S2507) or drugs (S3360) alone; other psychiatric illness (S4463) compared to those without (S1837); and employees' dependents (S4138) compared to employees (S2875) or their spouses (S2744). A significant minority also sought MHSA services in the medical sector. Understanding services use and associated costs can best be achieved by examining services use across treatment sectors. (C) 2004 Elsevier Inc. All rights reserved.